| Patient | Ulysses S. Grant |
|---|---|
| Date of birth | 1964-04-27 |
| Identifiers | MRN HR-NI002-SYN; SSN (made up) 000-02-9416 |
| Document date | 2026-07-21 |
| Author | Corinne Batiste, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Two-week follow-up on the day of the otolaryngology consultation and biopsy. [S]
Mr. Grant returns two weeks after his first visit, on the afternoon of his otolaryngology consultation. This morning the otolaryngologist examined him with a flexible laryngoscope, which showed an ulcerated lesion of the right tonsillar pillar with a clear larynx, and took a biopsy. The pathologist's same-day frozen section shows squamous cell carcinoma; p16 staining and the final report will follow within a few days. Last week's contrast CT of the neck showed a right tonsillar mass with one enlarged right level II lymph node. His throat pain is unchanged at 5 of 10. He takes the acetaminophen solution two or three times a day and uses the lidocaine rinse when the pain is worst. He manages soft foods and liquids and has lost 1 kg in two weeks. He smoked his last cigar a week ago, on the quit date set at his first visit, and has not smoked since. Varenicline taken without food made him queasy, so he stayed on 0.5 mg twice daily for an extra week; taken after meals it no longer causes nausea. He has noticed no change in mood, sleep, or dreams. He wants a treatment plan quickly so that he can keep working on his memoir. [S]
| Element | Detail |
|---|---|
| Workup today | Flexible laryngoscopy and biopsy; frozen section shows squamous cell carcinoma, p16 and final report pending |
| Imaging | Contrast CT of the neck last week: right tonsillar mass and one enlarged right level II node |
| Pain | 5 of 10, unchanged |
| Swallowing and weight | Soft foods and liquids; down 1 kg in two weeks |
| Tobacco | No cigars for one week, since the agreed quit date |
| Varenicline tolerance | Nausea only when taken without food; no mood or sleep change |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Weight down 1 kg in two weeks; no fever or night sweats |
| Ears, nose, mouth, and throat | Positive | Right-sided throat pain and painful swallowing; no ear pain or voice change |
| Respiratory | Negative | No cough, hemoptysis, or breathlessness |
| Gastrointestinal | Negative | No nausea when varenicline is taken after meals; no vomiting |
| Psychiatric | Negative | Worried about the diagnosis and the time it may take from his writing; no low mood; sleep and dreams unchanged |
5 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Varenicline 0.5 mg oral tablet, one tablet daily for three days, then one tablet twice daily | One tablet by mouth daily for three days, then twice daily | Oral route | 2026-07-07 to 2026-07-21 | completed | S |
| Varenicline 1 mg oral tablet, one tablet twice daily | One tablet by mouth twice daily after meals | Oral route | 2026-07-21 | active | S |
| Acetaminophen 160 mg/5 mL oral solution, 20 mL (640 mg) every 6 hours as needed for throat pain | 20 mL by mouth every 6 hours as needed for pain; no more than 3,000 mg a day | Oral route | 2026-07-07 | active | S |
| Lidocaine viscous 2% solution, 15 mL swish and spit up to every 3 hours as needed for throat pain | Swish 15 mL and spit up to every 3 hours as needed, no more than 8 doses a day; do not eat or drink for 60 minutes after use | Topical route | 2026-07-07 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-07-21 | Body height | 173 | cm | S |
| 2026-07-21 | Body weight | 77 | kg | S |
| 2026-07-21 | Body mass index (BMI) [Ratio] | 25.7 | kg/m2 | S |
| 2026-07-21 | Systolic blood pressure | 130 | mm[Hg] | S |
| 2026-07-21 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 2026-07-21 | Heart rate | 76 | /min | S |
| 2026-07-21 | Respiratory rate | 16 | /min | S |
| 2026-07-21 | Body temperature | 36.7 | Cel | S |
| 2026-07-21 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-07-21 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 5 | {score} | S |
Vital signs recorded on 2026-07-21; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Alert and composed; speaks in short stretches because talking aggravates the throat pain |
| Oropharynx | Ulcerated lesion of the right tonsillar pillar with a fresh biopsy site; no active bleeding |
| Neck | Firm, nontender right level II node, as on the CT; no other nodes |
| Lungs | Clear |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Squamous cell carcinoma of the right tonsillar pillar, p16-negative, suspected at presentation and confirmed by biopsy at the otolaryngology visit; linked to the documented 1885 diagnosis | active | confirmed | C09.1 | S — Synthetic diagnosis in the modern episode; the 1884-1885 findings remain D. |
| Nicotine dependence, cigars, about ten a day for more than forty years | active | confirmed | F17.290 | S — Synthetic modern diagnosis linked to documented heavy cigar smoking. |
| Painful swallowing with oropharyngeal dysphagia from the tonsillar tumor | active | confirmed | R13.12 | S — Synthetic symptom diagnosis echoing the documented painful swallowing. |
| Unintended weight loss from painful swallowing, about 2 kg before presentation | active | confirmed | R63.4 | S — Synthetic finding from the measured weights. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Head and neck examination with flexible laryngoscopy | At diagnosis | Completed today | Done by the otolaryngologist this morning: ulcerated right tonsillar pillar lesion; larynx clear |
| Laboratory | Biopsy with pathology and p16 immunohistochemistry | At diagnosis | Completed today | Biopsy taken this morning. The frozen section shows squamous cell carcinoma; p16 and the final report are pending |
| Imaging | Contrast-enhanced CT of the neck | At diagnosis | Up to date | Done last week: right tonsillar mass with one enlarged right level II node |
| Imaging | PET/CT for staging | Once carcinoma is confirmed | Ordered | Booked for next week |
| Referral | Otolaryngology–head and neck surgery | Urgently, within two weeks of presentation | Completed today | Seen today, two weeks after presentation |
| Referral | Multidisciplinary head and neck oncology team | After tissue diagnosis | Due | Referral to follow the final pathology report within days |
| Referral | Dental evaluation before radiation | Before radiation to the neck | Due | To be booked once the treatment plan is known |
| Referral | Speech-language pathology swallowing baseline | Before treatment | Due | To be booked with the dental evaluation |
| Referral | Dietitian assessment | Before treatment | Referred | Referred today because of painful swallowing and a 1 kg weight loss |
| Examination | Weight | Every visit | Completed today | 77 kg, down 1 kg (1.3 percent) from intake |
| Survey | Throat pain score (0-10) | Every visit | Completed today | 5 of 10, unchanged from intake |
| Survey | Depression screen (PHQ-2) | Every primary care visit after the diagnosis | Deferred | Not repeated today, because the visit was taken up by the new diagnosis. This departs from the care plan. He reports no low mood; the PHQ-2 is due at the post-staging visit |
| Laboratory | CBC, basic metabolic panel, and albumin | Before and after treatment | Due | Baseline normal at intake; repeat before treatment starts, at the post-staging visit |
| Laboratory | TSH | Baseline before neck radiation, then every 6 to 12 months after it | Up to date | 1.8 mIU/L at intake |
| Self-management | Tobacco use status and cessation counseling | Every visit | Completed today | No cigars for one week; counseling given |
| Medication safety | Varenicline tolerance: nausea, sleep, mood, and behavior | Each visit during treatment | Completed today | Nausea only when taken without food; no mood, sleep, or behavior change. Dose increased to 1 mg twice daily |
Goal progress:
Guideline basis: NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2025 (2025); Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021); CMID: Clinical Monitoring Intelligence Database, depression and hypothyroidism monographs (2026)
Follow-up: Telephone call with the final pathology report within a few days. PET/CT next week. Primary care visit after staging in about two weeks. Next scheduled visit 2026-08-04: primary care visit after staging to coordinate nutrition, dental care, tobacco cessation, and symptom control before treatment. [S]